BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Venture Capital Investment in Medical Devices Takes a Nosedive in Third Quarter Says PricewaterhouseCoopers LLP


12/3/2012 9:39:09 AM

Venture capital investment in medical devices pretty much fell off the cliff in the third quarter. The PricewaterhouseCoopers MoneyTree Report found that medical device companies received a combined $434 million from65 deals in the third quarter, which marks a 37 percent drop in dollar amount and a 27 percent decline in the number of deals from the second quarter. It’s hard to believe that just one quarter ago, the medical device industry ranked second in terms of venture investment into all industries; in the third quarter, it fell to sixth place. In fact, the third-quarter investment marks the lowest amount that the device industry pulled in since 2004. While the medical device industry sank to the bottom, overall, the life sciences sector showed signs of improvement, driven by a big influx in capital in the biotech industry, which saw a 64 percent increase from the same quarter a year ago. The life sciences group saw a total investment of $1.7 billion in the third quarter through 181 deals, which represented a 16 percent increase in the amount of dollars invested from the previous quarter, although the number of deals declined 2 percent from the second quarter of 2012. However, investment in life sciences companies in the third quarter continues a downward trajectory given that the dollar amount invested and the number of deals fell 12 percent and 8 percent respectively from the third quarter of 2011.

Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES